Diligence memo · auto-generated · as of July 2, 2026
Labvantage Lx Corp
Labvantage Lx Corp looks under-valued against its niche peers and is active on financing cadence.
Businessfiled
Labvantage Lx Corp operates in Other Health Care, based in NEW YORK.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Labvantage Lx Corp has raised $1.0M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $1.0M on —.
Valuation (modeled)modeled
Provath models Labvantage Lx Corp at approximately $1.6M (range $627K–$2.9M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.25× the median modeled value of Pre-Seed Other Health Care companies (2036 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
No dated round to assess.
Comparablesmixed
Capital scale ranks ahead of 35% of Other Health Care peers (5377 compared).
Modeled value ranks above 8% of those peers.
Peoplefiled
4 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.